Cardiogenic Shock in Older Adults : A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association
Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assessment and management of cardiogenic shock in this high-risk and growing population are lacking. Individual programs oftentimes develop upper age limits for various interventional strategies for their patients, including heart transplantation and durable left ventricular assist devices. However, age as a lone parameter should not be used to guide individual patient management decisions in cardiogenic shock. In the assessment of risk in older adults with cardiogenic shock, a comprehensive, interdisciplinary approach is central to developing best practices. In this American Heart Association scientific statement, we aim to summarize our contemporary understanding of the epidemiology, risk assessment, and in-hospital approach to management of cardiogenic shock, with a unique focus on older adults.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:149 |
|---|---|
| Enthalten in: |
Circulation - 149(2024), 14 vom: 02. Apr., Seite e1051-e1065 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Blumer, Vanessa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AHA Scientific Statements |
|---|
| Anmerkungen: |
Date Completed 03.04.2024 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIR.0000000000001214 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368968448 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368968448 | ||
| 003 | DE-627 | ||
| 005 | 20240404234853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIR.0000000000001214 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM368968448 | ||
| 035 | |a (NLM)38406869 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Blumer, Vanessa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiogenic Shock in Older Adults |b A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.04.2024 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assessment and management of cardiogenic shock in this high-risk and growing population are lacking. Individual programs oftentimes develop upper age limits for various interventional strategies for their patients, including heart transplantation and durable left ventricular assist devices. However, age as a lone parameter should not be used to guide individual patient management decisions in cardiogenic shock. In the assessment of risk in older adults with cardiogenic shock, a comprehensive, interdisciplinary approach is central to developing best practices. In this American Heart Association scientific statement, we aim to summarize our contemporary understanding of the epidemiology, risk assessment, and in-hospital approach to management of cardiogenic shock, with a unique focus on older adults | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a AHA Scientific Statements | |
| 650 | 4 | |a aging | |
| 650 | 4 | |a decision making | |
| 650 | 4 | |a frailty | |
| 650 | 4 | |a heart transplantation | |
| 650 | 4 | |a heart-assist devices | |
| 650 | 4 | |a risk assessment | |
| 650 | 4 | |a shock, cardiogenic | |
| 700 | 1 | |a Kanwar, Manreet K |e verfasserin |4 aut | |
| 700 | 1 | |a Barnett, Christopher F |e verfasserin |4 aut | |
| 700 | 1 | |a Cowger, Jennifer A |e verfasserin |4 aut | |
| 700 | 1 | |a Damluji, Abdulla A |e verfasserin |4 aut | |
| 700 | 1 | |a Farr, Maryjane |e verfasserin |4 aut | |
| 700 | 1 | |a Goodlin, Sarah J |e verfasserin |4 aut | |
| 700 | 1 | |a Katz, Jason N |e verfasserin |4 aut | |
| 700 | 1 | |a McIlvennan, Colleen K |e verfasserin |4 aut | |
| 700 | 1 | |a Sinha, Shashank S |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Tracy Y |e verfasserin |4 aut | |
| 700 | 0 | |a American Heart Association Cardiovascular Disease in Older Populations Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular Surgery and Anesthesia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d 1950 |g 149(2024), 14 vom: 02. Apr., Seite e1051-e1065 |w (DE-627)NLM000039020 |x 1524-4539 |7 nnns |
| 773 | 1 | 8 | |g volume:149 |g year:2024 |g number:14 |g day:02 |g month:04 |g pages:e1051-e1065 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIR.0000000000001214 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 149 |j 2024 |e 14 |b 02 |c 04 |h e1051-e1065 | ||